Pay in 4 interest-free payments of $81.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
1-Dimethylethyl-d9)-3-oxo-4-azaandrost-1-ene-17-carboxamide
Fmoc-Ser(α-Gal-β(1-3)-GalNAc)-OH
marketed for therapeutic use as Intron-A®
/ β-GlcNAc-PEG3-Azide / β-GlcNAc-PEG3-N3
SI230011: 8-Hydroxy Warfarin-d5 label-new 1-Dimethylethyl-d9)-3-oxo-4-azaandrost-1-ene-17-carboxamideC19H11D5O5 329. 36 CYP1A2 Metabolite of Warfarin 8 Hydroxy Warfarin d5 4,8 Dihydroxy 3 [3 oxo 1 (phenyl d5) butyl] 2H 1 benzopyran 2 one; 3 ( Acetonylbenzyl) 4,8 dihydroxycoumarin d5
US$ 162.50
US$ 118.80
US$ 171.50
US$ 157.50
